Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024)
Oruka Therapeutics (ORKA) recorded quarterly EPS (Basic) of -$0.18 in Q2 2024, down 28.57% quarter-over-quarter from -$0.14 in Q1 2024, and down 80.0% on a YoY basis from -$0.9 in Q3 2023.
Oruka Therapeutics (ORKA) EPS (Basic) (2010 - 2024) Analysis & Trends
Oruka Therapeutics' EPS (Basic) history runs 15 years deep, the most recent figure standing at -$0.18 for Q2 2024.
- In Q2 2024, EPS (Basic) fell 80.0% year-over-year to -$0.18; the TTM figure through Mar 2025 stood at -$0.18 (up 57.14% YoY), while the FY2023 annual figure was -$0.37, up 46.38% from the prior year.
- EPS (Basic) was -$0.18 for Q2 2024 at Oruka Therapeutics, down from -$0.14 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of -$0.08 in Q4 2022 to a low of -$0.83 in Q1 2020.
- Historically, EPS (Basic) has averaged -$0.29 across 5 years, with a median of -$0.22 in 2022.
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) soared 80.0% in 2022, then sank 80.0% in 2024.
- A 5-year view of EPS (Basic) shows it stood at -$0.61 in 2020, then soared by 34.43% to -$0.4 in 2021, then jumped by 80.0% to -$0.08 in 2022, then slipped by 0.0% to -$0.08 in 2023, then plunged by 125.0% to -$0.18 in 2024.
- The last three EPS (Basic) figures came in at -$0.18 (Q2 2024), -$0.14 (Q1 2024), and -$0.08 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | Oruka Therapeutics | 4.04 Bn | 3.65 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -0.18 |
| Mar 31, 2024 | -0.14 |
| Dec 31, 2023 | -0.08 |
| Sep 30, 2023 | -0.10 |
| Jun 30, 2023 | -0.10 |
| Mar 31, 2023 | -0.09 |
| Dec 31, 2022 | -0.08 |
| Sep 30, 2022 | -0.16 |
| Jun 30, 2022 | -0.22 |
| Mar 31, 2022 | -0.23 |
| Dec 31, 2021 | -0.40 |
| Sep 30, 2021 | -0.33 |
| Jun 30, 2021 | -0.34 |
| Mar 31, 2021 | -0.33 |
| Dec 31, 2020 | -0.61 |
| Sep 30, 2020 | -0.33 |
| Jun 30, 2020 | -0.73 |
| Mar 31, 2020 | -0.83 |
| Dec 31, 2019 | -0.69 |
| Sep 30, 2019 | -0.76 |